119 search results for: Pathophysiology

Bullous Pemphigoid Is an Autoimmune Disease Involving Dysregulated Type 2 Immune Response
Dermatology
Bullous Pemphigoid Is an Autoimmune Disease Involving Dysregulated Type 2 Immune Response
expert video

Listen as Dr. Donna Culton discusses the importance of crosstalk between autoantibodies and type 2 inflammation in the development of bullous pemphigoid.

View more
Key Pathophysiological Mechanisms of Chronic Spontaneous Urticaria Are Driven by Type 2 Inflammation
Dermatology
Key Pathophysiological Mechanisms of Chronic Spontaneous Urticaria Are Driven by Type 2 Inflammation
expert video

Join Dr. Jason Hawkes as he explains the importance of type 2 inflammation in chronic spontaneous urticaria.

View more
Cracking the Code: Diagnosing and Managing Skin Diseases With Type 2 Inflammation
Dermatology
Cracking the Code: Diagnosing and Managing Skin Diseases With Type 2 Inflammation
expert video

This symposium delves into the pivotal role of type 2 inflammation in diverse skin conditions, including atopic dermatitis, prurigo nodularis, chronic spontaneous urticaria, and bullous pemphigoid. It highlights both shared and distinct disease mechanisms and patient burdens, providing crucial insights for optimizing clinical management strategies through a series of engaging panel discussions with Drs Eichenfield, Elmariah, Culton, and Hawkes.

View more
Demystifying CPUO: Diagnosis and the Role of Type 2 Inflammation
Dermatology
Demystifying CPUO: Diagnosis and the Role of Type 2 Inflammation
expert video

Join Dr. Brian Kim in discussing the diagnosis of CPUO and the role of type 2 inflammation in disease pathophysiology.

View more
Inside the Hive: Type 2 Inflammatory Pathways in Chronic Spontaneous Urticaria
Dermatology
Inside the Hive: Type 2 Inflammatory Pathways in Chronic Spontaneous Urticaria
expert video

Join Dr. Jason Hawkes in discussing the burden of CSU and how type 2 inflammation contributes to the development of chronic wheals (hives) and angioedema

View more
Skin Dyspigmentation In Prurigo Nodularis (PN)
Dermatology
Skin Dyspigmentation In Prurigo Nodularis (PN)
interactivity

This infographic illustrates the clinical manifestations, pathophysiology and impact on patients of skin dyspigmentation in Prurigo Nodularis.

View more
Beneath the Surface: How Autoimmunity and Predominantly Type 2 Inflammation Mediate BP
Dermatology
Beneath the Surface: How Autoimmunity and Predominantly Type 2 Inflammation Mediate BP
expert video

Professor Ulrike Raap reviews the pathophysiology of BP, highlighting the role of type 2 inflammation, in this video from EADV 2025

View more
Mucus Plugging Is a Key Component of Remodeling in Asthma, Leading to Fixed Airway Obstruction
Pulmonology
Mucus Plugging Is a Key Component of Remodeling in Asthma, Leading to Fixed Airway Obstruction
Infographic

Learn about the role of type 2 inflammation in the burden and pathophysiology of mucus plugging in severe asthma

View more
The Path to Nodules: Type 2 Inflammation at the Core of Chronic Itch and Fibrosis in Prurigo Nodularis
Type 2 Inflammation
The Path to Nodules: Type 2 Inflammation at the Core of Chronic Itch and Fibrosis in Prurigo Nodularis
expert video

Join Dr. Shawn Kwatra in discussing the diverse clinical presentations of PN and the role of type 2 inflammation in disease pathogenesis.

View more
Chronic Spontaneous Urticaria Mechanism of Disease Animation
Dermatology
Chronic Spontaneous Urticaria Mechanism of Disease Animation
videoanimation

Explore the clinical presentation and pathophysiology of chronic spontaneous urticaria in this animated video. Learn about the complex mechanism of disease involving mast cell activation and the release of inflammatory mediators.

View more
Exploring the Potential Disease-Modifying Approaches in AD
Dermatology
Exploring the Potential Disease-Modifying Approaches in AD
interactivity

Explore the concept of disease modification in atopic dermatitis through this interactive infographic, which highlights potential considerations such as optimal sustained disease control, subclinical inflammation, the pathophysiology of AD, and atopic/non-atopic comorbidities.

View more